Director, Quantitative Pharmacology and Pharmacometrics – Oncology at Merck Sharp & Dohme Corp. /Netherlands

Upper Gwynedd Township, Pennsylvania, United States -

Full Time

Start Date

Immediate

Expiry Date

21 Aug, 26

Salary

300300.0

Posted On

23 May, 26

Experience

10 year(s) or above

Remote Job

Yes

Telecommute

Yes

Sponsor Visa

Yes

Skills

Clinical Pharmacology, Communication, Data Modeling, Data Visualization, Drug Development, Modeling Software, Pharmacology, Pharmacometrics, Program Leadership, Stakeholder Relationship Management

Industry

Pharmaceutical Manufacturing

Description

Job Description We are seeking an experienced talented scientist to join the Quantitative Pharmacology and Pharmacometrics – Immune/Oncology (QP2-IO) team in the role of Director. QP2-IO team is part of the Global Clinical Development organization and has oversight over drug development aspects related to clinical pharmacology and pharmacometrics of oncology drugs from post-PCC to registration. Directors are leaders in the field of quantitative drug development, with a strong, integrated understanding of the strategic elements of drug development. As a subject matter expert, the Director within the QP2-IO Group will work closely with teams of highly collaborative, cross-functional scientists to contribute to development of novel chemical entities. They develop strategies for quantitative analyses (and commensurate experiments/trials) within and across development programs and/or functions. Directors demonstrate outstanding leadership and communication skills. They collaborate within QP2-IO and with other functional areas, as well as with external vendors and partners, creating an aligned, quantitative framework to impact strategies and decisions of drug development teams. Primary Responsibilities: Serving as an expert representative for QP2 -IO on Oncology development teams. Framing critical questions and strategy for optimizing model-based analyses on programs. Developing and executing model-based analyses including translational PK/PD approaches, population pharmacokinetic models, exposure-response models, clinical trial design simulation, disease progression models, quantitative systems pharmacology (QSP) modeling, and comparator modeling. Strategizing and executing modeling of tumor size and survival. A Maintaining a comprehensive understanding of global regulatory expectations for small molecules and biologics in Oncology, authoring regulatory documents (investigational new drugs/INDs, clinical study reports (CSRs), clinical trial applications (CTDs), and representing QP2-IO at regulatory meetings. Mentoring and/or supervising junior staff to perform the above duties and to develop the above capabilities. Minimum education required: Ph.D. with at least seven years of pharmaceutical drug development experience relating to: PKPD, pharmacometrics, mathematics, statistics/ biostatistics, or chemical/biomedical engineering. Masters or PharmD, with at least nine years of experience, where “experience” means having a record of increasing responsibility and independence in a similar role in pharmaceutical drug development. Required Experience: Demonstrated impact with applications of pharmacometrics methods. Experience in IND, NDA and other submissions to global regulatory agencies. Skills in experimental design, mathematical problem solving, critical data analysis/interpretation, and statistics. An exemplary record of increasing responsibility, independence, and demonstrated impact in driving drug development decisions through application of model-based approaches. Proficiency in R, NONMEM,MATLAB, Monolix or other modeling software. Professional working proficiency in written and verbal communication. The remote position is only applicable for those that are not within commutable distance to primary sites noted in posting. If commutable, the position will be hybrid. Please note that standard commute is (less than)

How To Apply:

Incase you would like to apply to this job directly from the source, please click here

Responsibilities

Lead quantitative drug development strategies for oncology programs, focusing on model-based analyses and translational PK/PD approaches. Collaborate with cross-functional teams and regulatory agencies to impact drug development decisions and author critical regulatory documents.